The Female Reproductive toxicity of EDCs project: a human evidence-based screening and dentification approach (FREIA) is EU-funded.

It aims to improve the  identification of chemicals that affect women’s health via disruption of the hormone system. 

HEAL collaborates on policy and advocacy actions as well as  dissemination and communication on health protection.

11 partners contribute from the Netherlands, UK, Denmark, Sweden, Belgium, France, Estonia, and the USA.

The main objective of this project is to provide dedicated, human-relevant, test methods to identify EDCs that cause female reproductive toxicity.

FREIA will generate and integrate scientific data on the effects of EDCs on female reproductive health, specifically on ovarian development and function and the subsequent consequences for female fertility. These data will be used to develop a test strategy with dedicated test methods to assess female reproductive toxicity and provide the basis to develop health preventive options.